Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM vs MEROPENEM ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM vs MEROPENEM ANHYDROUS: Safety Overview

Metric MEROPENEM MEROPENEM ANHYDROUS
Total FAERS Reports 13,867 144
Deaths Reported 3,880 25
Death Rate 28.0% 17.4%
Hospitalizations 7,167 102
Average Patient Age 51.1 yrs 55.0 yrs
% Female Patients 42.9% 44.2%
FDA Approval Date Apr 12, 2016 N/A
Manufacturer Eugia US LLC Mylan Institutional LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A